Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

18 Biggest Mid-Day Gainers For Monday

CMRE, SGLY, BLFS, XOMA, MYSZ, TSEM, ON, AXTI

  • My Size, Inc. (NASDAQ: MYSZ) shares surged 107.8 percent to $8.00. MySize disclosed that it has signed PNO Consultants with plans to expand offices to Poland.
  • Zosano Pharma Corp (NASDAQ: ZSAN) shares jumped 77 percent to $2.12 after the company disclosed that M207 has achieved both co-primary endpoints in ZOTRIP pivotal efficacy migrane trial.
  • Sino-Global Shipping America, Ltd. (NASDAQ: SINO) shares gained 54.9 percent to $4.21. Sino-Global reported Q2 earnings of $0.11 per share on revenue of $2.129 million.
  • Protalix Biotherapeutics Inc (NYSE: PLX) rose 35.6 percent to $1.37. Protalix BioTherapeutics reported that it will participate in the 13th Annual WORLDSymposium™ 2017.
  • Electromed, Inc. (NYSE: ELMD) shares gained 17.2 percent to $4.76. Electromed shares have gained 6.01 percent over the past 52 weeks, while the S&P 500 index has climbed 22.18 percent in the same period.
  • XOMA Corporation (NASDAQ: XOMA) surged 15.1 percent to $4.64. XOMA priced its $25 million offering at $4.03 per share.
  • Chemours Co (NYSE: CC) shares climbed 15 percent to $32.32 as DuPont reached a global $670.7 million settlement of multi-district PFOA litigation.
  • Trio-Tech International (NYSE: TRT) shares surged 13.6 percent to $4.35. On Friday, Trio-Tech reported Q2 earnings of $0.09 per share on revenue of $9.1 million.
  • SAGE Therapeutics Inc (NASDAQ: SAGE) shares gained 13.2 percent to $53.68. Sage Therapeutics disclosed that it has advanced Sage-217 to Phase 2 in major depressive disorder on positive signal of activity and tolerability.
  • Zeltiq Aesthetics Inc (NASDAQ: ZLTQ) shares surged 12.6 percent to $55.60. Allergan plc (NYSE: AGN) announced plans to acquire Zeltiq Aesthetics for $2.47 billion.
  • Flagstar Bancorp Inc (NYSE: FBC) gained 9 percent to $28.04. PiperJaffray upgraded Flagstar Bancorp from Neutral to Overweight.
  • AXT Inc (NASDAQ: AXTI) shares climbed 8.1 percent to $6.70. Dougherty initiated coverage on AXT with a Buy rating.
  • Costamare Inc (NYSE: CMRE) shares surged 7.5 percent to $6.00. Stifel Nicolaus upgraded Costamare from Sell to Hold, while Wells Fargo upgraded the stock from Market Perform to Outperform.
  • ON Semiconductor Corp (NASDAQ: ON) climbed 5.9 percent to $14.97 after the company reported better-than-expected quarterly results.
  • Inovio Pharmaceuticals Inc (NASDAQ: INO) gained 4 percent to $6.64. Inovio and ApolloBio agreed to collaborate on the development and commercialization of HPV pre-cancer immunotherapy VGX-3100 in Greater China.
  • Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) shares gained 3.7 percent to $33.38 after the company posted upbeat quarterly results.
  • Tower Semiconductor Ltd. (USA) (NASDAQ: TSEM) gained 3.4 percent to $22.83 after the company posted upbeat quarterly profit.
  • BioLife Solutions Inc (NASDAQ: BLFS) shares rose 2.1 percent to $2.11. BioLife Solutions projects FY2017 sales of $10.0 million.

Latest Ratings for AGN

Date Firm Action From To
Nov 2016 Morgan Stanley Maintains Overweight
Oct 2016 Barclays Assumes Equal-Weight
Aug 2016 Mizuho Upgrades Neutral Buy

View More Analyst Ratings for AGN
View the Latest Analyst Ratings



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today